Commerzbank’s Takeover Saga Fizzles as UniCredit Musters Only 17.6% Acceptance
Published on 07/22/2026 at 09:50 | Redaktion boerse-global.de
The battle for control of Commerzbank has reached a decisive, if anticlimactic, juncture. UniCredit’s extended offer period expired on July 3, 2026, with just 17.60% of shareholders having tendered their shares — a result the Italian lender must view as a clear rebuff. Crucially, fewer than 2 percentage points of that total came from independent institutional or retail investors, according to Commerzbank’s own tally. The overwhelming majority of tendered shares originated from within UniCredit’s own orbit, leaving the Milan-based group far short of the broad shareholder support it had hoped to secure.
That outcome has not, however, left Commerzbank without suitors. Jefferies Financial Group, the U.S. investment bank, has quietly built its voting rights in the German lender to 10.02%, up from 9.91% previously. The 10% threshold was crossed on July 15, 2026, and the position is split between 2.52% held directly in shares and 7.50% held via financial instruments. The stock itself traded at €37.71 on the day, slipping 0.24%, though the 12-month gain of 30.89% underscores that the failed takeover bid has done little to dim longer-term investor enthusiasm.
Profit Targets Raised as Payout Promise Steals the Show
With the ownership question at least temporarily settled, Commerzbank’s management moved swiftly to refocus attention on fundamentals. On July 14, 2026, the board lifted its net profit target for the current financial year to at least €3.4 billion, up from a prior goal of more than €3.2 billion. Even more eye-catching was the dividend announcement: for the 2026 through 2028 period, the bank intends to return nearly 100% of earnings after AT1 coupon payments to shareholders via a combination of dividends and share buybacks. That follows the May 20, 2026 annual general meeting, which approved a dividend of €1.10 per share for fiscal 2025 — up sharply from €0.65 the prior year — and granted a new buyback authorization covering up to 10% of share capital.
These payout ambitions are anchored by the medium-term targets embedded in the “Momentum 2030” strategy, which the bank has reaffirmed. Management continues to target a return on equity of 21% by the end of the decade. Yet the strategy also carries a cost: the elimination of roughly 3,000 full-time positions by 2030, a headwind that tempers the otherwise bullish profit narrative.
Should investors sell immediately? Or is it worth buying Commerzbank?
Analyst Confidence and Industry Accolades
Deutsche Bank Research weighed in on July 15 with a “Buy” rating and a €42.00 price target. Analyst Benjamin Goy cited expectations of strong earnings growth in the second quarter, driven by robust interest income. The current share price sits 3.75% below the 52-week high of €39.18, which the stock touched on July 14 — suggesting Goy sees further upside still in play.
Operationally, Commerzbank has also garnered external validation. At the 2026 FINANCE Awards, the institution swept three categories: Best Bank in German Corporate Banking, Best Bank for Mittelstand clients, and the top service-level award — a triple win that underscores its entrenched position in the domestic business banking landscape.
The Regulatory Cloud That Won’t Lift
Despite UniCredit’s failed tender, the takeover drama is far from over. The Italian bank still holds effective access to a significant portion of Commerzbank’s capital and nearly half of its voting rights on a pro-forma basis — but actual control remains contingent on regulatory approval, which has yet to materialize. That limbo continues to cast a shadow over the stock’s valuation. The German government, Commerzbank’s second-largest shareholder, has not confirmed any sale negotiations, leaving the political dimension unresolved.
The uncertainty cuts both ways. On the bullish side, the stock trades 8.63% above its 200-day moving average of €34.66, signaling a healthy long-term uptrend. The relative strength index sits at a neutral 51.3, suggesting room for further gains without overheating. The prospect of a future merger with HypoVereinsbank and the possibility that UniCredit might call an extraordinary general meeting to push for supervisory board seats both act as a floor under the share price.
But the risks are equally real. Germany’s credit market is showing signs of strain, with the latest KfW credit market outlook pointing to stagnation in new lending amid geopolitical tensions, elevated energy costs, and higher interest rates — all of which directly threaten Commerzbank’s core Mittelstand franchise. There is also the concern that the prolonged regulatory limbo could induce strategic paralysis, and that dividend policy might be adjusted to free up cash for integration costs if the deal eventually goes through.
Commerzbank at a turning point? This analysis reveals what investors need to know now.
Chart Levels to Watch
Technically, the stock is caught between two key markers. As long as it holds above the 50-day moving average of €37.16, the path remains open for a retest of the €39.18 high. A clean break above that level would constitute a strong buy signal. Should the shares slip below €37.16, however, the next support lies at the 100-day moving average of €35.25, and a breach there would darken the medium-term technical picture.
All eyes now turn to August 6, 2026, when Commerzbank releases its second-quarter results. That report will offer the first hard evidence of whether the bank’s upgraded profit guidance and aggressive payout strategy are backed by genuine operating momentum. The third-quarter numbers are scheduled for November 5. But the truly decisive event remains the regulatory verdict on UniCredit’s control bid — a decision that will ultimately determine how the €40.41 billion lender is valued for years to come.
Ad
Commerzbank Stock: New Analysis - 22 July
Fresh Commerzbank information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
